Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin effect on imatinib pharmacokinetics in GIST
NL-OMON21949Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Nov 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of imatinib and rosuvastatin in gastrointestinal stromal tumor (GIST), sponsored by Erasmus MC. Primary endpoint: Influence of rosuvastatin on plasma pharmacokinetics of imatinib and CGP74588. Planned start Nov 2008; status: not yet recruiting.
02
Drugs
imatinibrosuvastatin
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NL-OMON21949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21949.